Decision Historical Cash Flow

DECN Stock  USD 0.0001  0.00  0.00%   
Analysis of Decision Diagnostics cash flow over time is an excellent tool to project Decision Diagnostics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 854.9 K or Net Borrowings of 2.5 M as it is a great indicator of Decision Diagnostics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Decision Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Decision Diagnostics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.

About Decision Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Decision balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Decision's non-liquid assets can be easily converted into cash.

Decision Diagnostics Cash Flow Chart

At this time, Decision Diagnostics' Change To Netincome is very stable compared to the past year. As of the 30th of November 2024, Change To Liabilities is likely to grow to about 542.3 K, while Change To Inventory is likely to drop 5,093.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.

Capital Expenditures

Capital Expenditures are funds used by Decision Diagnostics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Decision Diagnostics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Depreciation

Depreciation indicates how much of Decision Diagnostics value has been used up. For tax purposes Decision Diagnostics can deduct the cost of the tangible assets it purchases as business expenses. However, Decision Diagnostics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most accounts from Decision Diagnostics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Decision Diagnostics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.At this time, Decision Diagnostics' Change To Netincome is very stable compared to the past year. As of the 30th of November 2024, Change To Liabilities is likely to grow to about 542.3 K, while Change To Inventory is likely to drop 5,093.
 2010 2023 2024 (projected)
Issuance Of Capital Stock300K270K240K
Other Non Cash Items449.9K30.7M32.2M

Decision Diagnostics cash flow statement Correlations

-0.490.030.260.220.010.06-0.080.04-0.050.02-0.08-0.050.10.080.09-0.07-0.05
-0.49-0.25-0.4-0.28-0.310.11-0.050.190.020.06-0.030.020.030.030.03-0.030.02
0.03-0.250.730.31-0.23-0.750.770.35-0.440.490.76-0.44-0.65-0.76-0.760.76-0.44
0.26-0.40.730.85-0.45-0.860.860.6-0.550.580.86-0.55-0.71-0.86-0.850.87-0.55
0.22-0.280.310.85-0.4-0.740.70.66-0.40.40.71-0.4-0.62-0.71-0.710.71-0.4
0.01-0.31-0.23-0.45-0.40.46-0.5-0.440.27-0.87-0.50.270.440.50.5-0.50.27
0.060.11-0.75-0.86-0.740.46-0.98-0.780.45-0.63-0.990.450.910.990.99-0.980.45
-0.08-0.050.770.860.7-0.5-0.980.8-0.60.691.0-0.6-0.83-0.99-0.991.0-0.6
0.040.190.350.60.66-0.44-0.780.8-0.520.490.8-0.52-0.65-0.8-0.790.8-0.52
-0.050.02-0.44-0.55-0.40.270.45-0.6-0.52-0.47-0.551.00.170.540.5-0.611.0
0.020.060.490.580.4-0.87-0.630.690.49-0.470.67-0.47-0.53-0.67-0.660.67-0.47
-0.08-0.030.760.860.71-0.5-0.991.00.8-0.550.67-0.55-0.87-1.0-1.01.0-0.55
-0.050.02-0.44-0.55-0.40.270.45-0.6-0.521.0-0.47-0.550.170.540.5-0.611.0
0.10.03-0.65-0.71-0.620.440.91-0.83-0.650.17-0.53-0.870.170.870.89-0.840.17
0.080.03-0.76-0.86-0.710.50.99-0.99-0.80.54-0.67-1.00.540.871.0-1.00.54
0.090.03-0.76-0.85-0.710.50.99-0.99-0.790.5-0.66-1.00.50.891.0-0.990.5
-0.07-0.030.760.870.71-0.5-0.981.00.8-0.610.671.0-0.61-0.84-1.0-0.99-0.61
-0.050.02-0.44-0.55-0.40.270.45-0.6-0.521.0-0.47-0.551.00.170.540.5-0.61
Click cells to compare fundamentals

Decision Diagnostics Account Relationship Matchups

Pair Trading with Decision Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.